ACCEPTED ABSTRACTS FOR POSTER PRESENTATION

1. HARPAGOPHYTUM PROCUMBENS (DEVIL'S CLAW): A POSSIBLE NATURAL ANTI-INFLAMMATORY AGENT (AN EXPERIMENTAL STUDY)
I. Hamdy Younos, M. Ibrahim Ahmed, M. Ismael Afifi
Clinical pharmacology department, Faculty of medicine, Minufiya University, Shebeen Al Koam, Minufiya, Egypt

2. ASSESSMENT OF THE ANTI-INFLAMMATORY ACTIVITY OF TOMATINE AND TOMATINE HYALURONATE
Mihaela Albulescu, Georgeta Caraene, Radu Albulescu, Georgeta Radulescu,
National Institute for Chemical-Pharmaceutical Research & Development (ICCF) Bucharest, Roman

3. EFFECTS OF QUANTUM THERAPY ON SOME INFLAMMATORY MARKERS AND CIRCULATING T-LYMPHOCYTES IN ACUTE CORONARY SYNDROME
I.G.Alizade, N.T.Aliyeva-Karayeva, Cardiology Department, Hospital of Ministry of Internal Afairs, Baku, Azerbaijan

4. ANTIOXIDANT VERSUS ANTICANCER/ANTI-INFLAMMATORY PROPERTIES OF PHENOLIC DERIVATIVES: A NEW CHALLENGE ON STRUCTURE- ACTIVITY STUDIES
R. Calheiros1, J.B. Sousa1, S.M. Fiúza1, A. Gaspar2, N. Milhazes2, J. Garrido3, C. Siquet4, S. Reis4, C. Diniz5, P. Fresco5, M.P.M. Marques1,6, F. Borges1,2

5. ANTIOXIDANT PROPERTIES OF SOME SYNTHETIC QUERCETIN HYDROXYETHYLATED DERIVATIVES
G. Caraene, M. Albulescu, C. Ghita , A. Albulescu , L. Bud, I. Paraschiv
The National Institute for Chemical-Pharmaceutical Research & Development (ICCF) Bucharest, Romania

6. Synthesis and SAR of N-substituted 1,2,4-Oxadiazol-5(4H)-one Derivatives as sPLA2 IIA Inhibitors.
D. KAUMEMAT N’GOMBIa, F. CHAUa, A. DJIMBEa
G. DIVEb, J. HUETa, F. MASSICOTa, F. HEYMANSa,*
a Unité de Pharmacochimie Moléculaire et Systèmes Membranaires, EA2381,
Université Paris 7-Denis Diderot France.
b Centre d’Ingénierie des Protéines, Institut de Chimie, Université de Liège, Belgium.

7. HUMAN ADULT PERIODONTAL DISEASE AS A MODEL FOR RHEUMATOID ARTHRITIS
Robert A. Greenwald, M.D., Long Island Jewish Medical Center, Lake Success NY 11042

8. PROSTAGLANDIN E2 AUGMENTS IL-10 SIGNALING AND FUNCTION
HyeonJoo Cheon1, Young Hee. Rho2, Seong Jae. Choi2, Young Ho. Lee2, Gwan Gyu. Song2, Jeongwon Sohn3, Nam H. Won1, Jong Dae. Ji2
Department of 1Pathology, 2Rheumatology, 3Biochemistry, College of Medicine, Korea University, Seoul, Korea

9. CAFFEIC ACID PHENYL ESTER PREVENTS THE Th-2 IMMUNE RESPONSE AFTER ABDOMINAL -IRRADIATION IN THE ILEUM MUCOSA OF RAT
O.Gremy, M. Benderitter, C. Linard
Institut de Radioprotection et de Sûreté Nucléaire, Laboratoire de radio-pathologie, BP17, F-92262 Fontenay aux Roses.

10. Oxidative stress and neutrophil superoxide release in patients with Crohn's disease: distinction between active and non-active disease
Rainis T*., Maor I**., Lanir A.,** Lavy A.*
*Gastroenterology Unit, Bnai-Zion Medical Center, Haifa, Israel
**Department of Biochemistry, Bnai-Zion Medical Center, Haifa, Israel

11. MICROMETHASON – A LIPOSOMAL GLUCOCORTICOID FOR INTRAVENOUS TREATMENT OF RAT ANTIGEN-INDUCED ARTHRITIS (AIA)
Una Rauchhaus1, Reiner Schulte2, Raimund Kinne2, Rolf Bräuer3, Steffen Panzner1
1novosom AG, Halle, GERMANY
2 Experimental Rheumatology Unit, 3Institute of Pathology, Friedrich Schiller University, Jena, GERMANY

12. RELATIONSHIP BETWEEN THE ABILITY OF NSAIDS TO ALTER THE MEMBRANE FLUIDITY AND THEIR ANTIOXIDANT ACTIVITY
S. Reis, H. Ferreira, M. Lúcio, J. L. F. C. Lima
REQUIMTE, Departamento de Química – Física, Faculdade de Farmácia, Universidade do Porto, Rua Aníbal Cunha, 164, 4099-030 Porto, Portugal

13.Intestinal anti-inflammatory and anti-neoplasic effects of 5-aminosalicylic acid (5-ASA) are dependent on PPAR gamma (PPAR) expression and activation
Christel Rousseaux*, Bruno Lefebvre**, Laurent Dubuquoy***, Philippe Lefebvre**, Olivier Romano*, Johan Auwerx***, Daniel Metzger***, Walter Wahli****, Béatrice Desvergne****, Gian Carlo Naccari*****, Philippe Chavatte******, Amaury Farce******, Philippe Bulois*, Antoine Cortot*, Jean Frédéric Colombel* and Pierre Desreumaux*

14. EXPRESSION OF PROSTAGLANDIN METABOLISM ENZYMES IN MEDULLARY THYROID CANCER AND ANTITUMORAL EFFECT OF A NON STEROIDAL ANTI-INFLAMMATORY DRUG, INDOMETHACIN.
V. Quidville, N. Segond, R. Cohen, A. Martin, M. Wassef, A. Jullienne and S. Lausson.
INSERM U606, Hopital Lariboisière, 2 rue A. Paré, 75475 Paris cedex 10, France

15.THIAZOLIDINEDIONES DECREASE NEURONAL DAMAGE FOLLOWING TRAUMATIC AND ISCHEMIC INSULTS TO CNS BY CONTROLLING INFLAMMATION
R. Vemuganti, S. Park, R. Sundaresan, K. Bowen, K. Tureyen, I. Satriotomo, G. Miranpuri D.K. Resnick
Department of Neurological Surgery and the Neuroscience Training Program, University of Wisconsin, Madison WI USA

16. APOCYNIN AND GUAIACOL: TWO SIMILAR METHOXY-CATECHOLS WITH VERY DIFFERENT ANTIINFLAMMATORY PROPERTIES
VF Ximenes, SO Silva, A Campa, LM Fonseca, IZ Carlos, OMM Oliveira, IL Brunetti
Faculdade de Ciências Farmacêuticas de Araraquara, Universidade do Estado de São Paulo, Brasil.

17. THE GHRELIN AGONIST GHRP-2 PREVENTS THE EFFECT OF LPS ON HEPATIC TNF alpha mRNA AND ON SERUM IGF-I.
Granado M, Martín AI, Castillero E, Villanúa MA, López-Calderón A.

18.PROTEINASE ACTIVATED RECEPTOR-2 (PAR2) ACTIVATION UPON PORPHYROMONAS GINGIVALIS INFECTION PARTICIPATES TO INNATE IMMUNE RESPONSE
M. Holzhausen, L. C. Spolidorio, M. Steinhoff, P. Andrade-Gordon, N. Vergnolle- Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Calgary, Alberta, Canada.

19. Selenium: new advances in Bronchial Asthma patients.
J.Voicehovska, A.Ivanovs, Prof. G.Orlikovs, I.Baidekalne, Riga Stradins University, Internal diseases department, Riga, Latvia; A.Skesters Riga Stradins University Biochemical Laboratory.

20. Tripterine inhibits the expression of adhesion molecules in activated endothelial cells
Deng-hai Zhang1,2,* , Anthony Marconi, Li-Min Xu, Chun-xin Yang 3, Guo-wu Sun4, Xiao-ling Feng4, Shu-min Xu2, Chang-quan Ling5, Wan-zhang Qin3, Georges Uzan1,, and Patrizia d’Alessio†

1 INSERM U602, Hôpital Paul Brousse, 12, avenue Paul Vaillant-Couturier, 94807 Villejuif, France; 2Shanghai East Hospital, Tongji Univeristy, Shanghai; 3Zhongshan Hospital, Fudan University, Shanghai; 4 Shanghai Pudong Gongli Hospital, Shanghai, 5Changhai Hospital, Shanghai Second Military Medical University, Shanghai, China.

 

ACCEPTED ABSTRACTS FOR ORAL PRESENTATION

1. Evaluation of Statin in Decreasing the Early Mortality and Morbidity of Acute Coronary Syndrome
A Clinical Trial in Shaheed Rajaie Cardiovascular Medical and Research Center
Shahmohammadi Mousavi A.MD (1), Peighambari MM. MD (1), Madani M. MD (1), Zafaranloo N. MD

2. ANTI-INFLAMMATORY AND ANTI-ARTHRITIC ACTIVITY OF 2-METHOXYESTRADIOL IN A RAT MODEL OF COLLAGEN-INDUCED ARTHRITIS
Ernest Brahn1, Mona L. Banquerigo1, John Lee1, William E. Fogler2, Stacy M. Plum2
1UCLA School of Medicine, Los Angeles, CA & EntreMed, Inc., Rockville, MD

3. Inhibition of acute and chronic lung inflammation by a novel PDE 4 inhibitor
Isabelle Couillin, Caroline Mary, Isabelle Maillet, Bernhard Ryffel, Philippe Bernard

4. Signaling Pathways and the Future of Anti-inflammatory Drugs
CNRS, IEM2815, and Green Pharma, SA, Orleans, France
Alan J. Lewis, Signal Pharmaceuticals, Celgene, San Diego, CA

5. MODULATION OF HUMAN LYMPHOCYTE FUNCTIONS IN VITRO BY A PROSTANOID EP2 RECEPTOR AGONIST
J.G. Zhang, R. L. G. Sheldrick, M. Ali, R. A. Borman and K. L. Clark
Pharmagene Laboratories Ltd, Royston, SG8 5HD, UK

6. PHENOLIC DERIVATIVES: A STUDY ON THE RELATIONSHIP BETWEEN STRUCTURE, ACTIVITY AND PHYSICOCHEMICAL PARAMETERS
F. Borges1,2, R. Calheiros1, J.B. Sousa1, S.M. Fiuza1, A. Gaspar2, N. Milhazes2, F. Roleira3, E. Tavares da Silva3, J. Garrido4, E. Garrido4, C. Siquet5, S. Reis5, L.A.E. Batista de Carvalho, M.P.M. Marques1,6